IL2 and Merkel cell skin cancer: Indeed, our results show that MCC cells were sensitive to EpCAM-ReTARGTPRIFNαR149A-induced growth inhibition, and they were more effectively eliminated by TPR/IL2-expanded PBMCs compared to EpCAM-ReTARGTPR.